Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | LIG1 | P18858 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11767364 | 0.92 | AKR1C3 (0.44) | ALDH1A1SMN1; SMN2TSHRTP53GAA | |
| SCHEMBL83996 | 0.90 | AKR1C3 (0.46) | ALDH1A1SMN1; SMN2TSHRTP53GAA | |
| SCHEMBL278676 | 0.87 | PTPN1 (0.47) | ALDH1A1SMN1; SMN2TSHRMAPTPTPN1 | |
| SCHEMBL655212 | 0.86 | KDM4E (0.46) | ALDH1A1SMN1; SMN2TSHRTP53GAA | |
| SCHEMBL21084683 | 0.86 | PTPN1 (0.44) | ALDH1A1SMN1; SMN2TSHRTP53GAA | |
| SCHEMBL11223527 | 0.84 | KMT2A (0.38) | ALDH1A1SMN1; SMN2TSHRTP53GAA | |
| SCHEMBL10692029 | 0.83 | PTPN1 (0.43) | ALDH1A1SMN1; SMN2TSHRTP53GAA | |
| SCHEMBL8946208 | 0.81 | CYP1A2 (0.41) | ALDH1A1SMN1; SMN2GAAMAPTPTPN1 | |
| SCHEMBL11120795 | 0.80 | HPGD (0.59) | ALDH1A1SMN1; SMN2TP53MAPTCYP3A4 | |
| SCHEMBL2538164 | 0.80 | CYP3A4 (0.68) | ALDH1A1SMN1; SMN2TSHRGAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7534839-B2 | Sequentially terminated elastomers | BRIDGESTONE CORPORATION (JP) | 2009-05-19 | — | — | US | claimed |
| JP-2007500281-A | — | — | 2007-01-11 | — | — | JP | claimed |
| US-20060135701-A1 | Hysteresis elastomeric compositions comprising sequentially terminated polymers | BRIDGESTONE CORPORATION (JP) | 2006-06-22 | — | — | US | claimed |
| EP-1631596-A1 | IMPROVED HYSTERESIS ELASTOMERIC COMPOSITIONS COMPRISING SEQUENTIALLY TERMINATED POLYMERS | Bridgestone Corporation (JP) | 2006-03-08 | — | — | EP | claimed |
| WO-2004111094-A1 | IMPROVED HYSTERESIS ELASTOMERIC COMPOSITIONS COMPRISING SEQUENTIALLY TERMINATED POLYMERS | BRIDGESTONE CORPORATION (JP) | 2004-12-23 | — | — | WO | claimed |
| EP-0203393-B1 | CURABLE COMPOSITION | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1989-07-12 | — | — | EP | claimed |
| US-4778859-A | Tetramine derived polyimide with pendant unsaturation, and various photosensitive compositions therefrom | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1988-10-18 | — | — | US | claimed |
| EP-0203393-A1 | Curable composition | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1986-12-03 | — | — | EP | claimed |
| JP-60078443-A | — | — | None | — | — | JP | disclosed |
| JP-6003820-A | — | — | None | — | — | JP | disclosed |
| EP-4378928-A1 | NAPHTHALENE DITHIOL AND DERIVATIVE THEREOF, AND PRODUCTION METHODS AND USES FOR SAME | SUGAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2024-06-05 | — | — | EP | disclosed |
| WO-2023195346-A1 | ULTRAVIOLET ABSORBENT | 大阪ガスケミカル株式会社 | 2023-10-12 | — | — | WO | disclosed |
| WO-2023169352-A1 | BENZOPHENONE DERIVATIVE, METHOD FOR PREPARING SAME, AND USE THEREOF | 艾坚蒙(安庆)科技发展有限公司 | 2023-09-14 | — | — | WO | disclosed |
| US-20230288748-A1 | LIGHT ABSORPTION FILTER, OPTICAL FILTER, SELF-LUMINOUS DISPLAY DEVICE, ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, AND LIQUID CRYSTAL DISPLAY DEVICE, AND MANUFACTURING METHOD FOR OPTICAL FILTER | FUJIFILM CORPORATION (JP) | 2023-09-14 | — | — | US | disclosed |
| EP-0127574-A2 | Light cross-linkable composition | CIBA-GEIGY AG (CH) | 1984-12-05 | — | — | EP | disclosed |
| EP-0126029-A2 | Image-forming process | CIBA-GEIGY AG (CH) | 1984-11-21 | — | — | EP | disclosed |
| EP-0102921-A2 | Process for making images from liquid substances | CIBA-GEIGY AG (CH) | 1984-03-14 | — | — | EP | disclosed |
| US-4276352-A | Reinforced composites containing unsaturated polyimide resins | CIBA-GEIGY CORPORATION (US) | 1981-06-30 | — | — | US | disclosed |
| US-4254012-A | Reinforced composites containing cyanato resins | CIBA-GEIGY CORPORATION (US) | 1981-03-03 | — | — | US | disclosed |
| US-4252593-A | Method of preparing reinforced composites | CIBA-GEIGY CORPORATION (US) | 1981-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230288748-A1 | LIGHT ABSORPTION FILTER, OPTICAL FILTER, SELF-LUMINOUS DISPLAY DEVICE, ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, AND LIQUID CRYSTAL DISPLAY DEVICE, AND MANUFACTURING METHOD FOR OPTICAL FILTER | NLRP1, NLRP3, STRA6 | ALDH1A1 293/4885SMN1; SMN2 4446/4885TSHR 2218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.